LINDSAY HENDERSON: Open Payments
NPI 1033441233 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,055 in 124 payments from 28 companies in 2025. Trend: 2023 $2,135 · 2024 $2,002 · 2025 $2,055
Food & beverage: $2,055
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $215 |
| PFIZER INC. | 19 | $192 |
| Novo Nordisk Inc | 13 | $176 |
| GlaxoSmithKline, LLC. | 13 | $175 |
| ABBVIE INC. | 8 | $136 |
| Lundbeck LLC | 6 | $124 |
| Neurocrine BioSciences, Inc. | 5 | $93 |
| SHIELD THERAPEUTICS INC | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Astellas Pharma US Inc | 3 | $75 |
Products named: REXULTI, ELIQUIS, TRELEGY ELLIPTA, INGREZZA, ACCRUFER, Wegovy, AIRSUPRA, Ozempic.
Industry payments across TN — which companies pay providers there.
